Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

NervGen Pharma: Proof that NVG-291 works?

It’s arguably a Eureka moment for investors in NervGen Pharma (TSX.V: NGEN) (OTCQB: NGENF). Tantalizing anecdotal “evidence” has just been published that suggests that NervGen’s prospective wonder-drug — NVG-29...
Knox Henderson | December 23, 2024 |

Buzz on the Bullboards: More tricks or treats this investing season?

Hallowe’en is always a spooky season, between next week’s U.S. election, the spreading battles across the globe, and the cost of living … there is plenty to be scared about. Even so, your stock portfolio need not be one of those things. ...
Jonathon Brown | October 31, 2024 |

Prospera Energy corporate update: 3 years of strategic restructuring, recovery and future growth

CALGARY, Alberta, Oct. 24, 2024 (GLOBE NEWSWIRE) — Prospera Energy Inc. (“PEI”) (TSX.V: PEI, OTC: GXRFF, FRA: OF6B) The 2024 Prospera corporate update outlines the company’s restructuring efforts since 2021, highlighting key m...
Research | October 25, 2024 |

Level up your trading with BMO InvestorLine’s enhanced features

With about 48 per cent of Canadians investing regularly, according to an Ipsos poll conducted in February, and more young people learning about the benefits of putting money to work than ever before, the demand for leading-edge trading platforms in terms of efficienc...
Trevor Abes | October 4, 2024 |

Gaming stocks that are worth tracking

Gaming has evolved from a pastime activity to become a career for some people and an educational tool for others. Gaming has produced some of the biggest global companies, such as Sony, Meta, Microsoft, and Tencent Holdings. How did companies like Microsoft and Meta get a...
Research | July 29, 2024 |

NervGen: Are amazing human trial results leaking out?

“We are very excited! We are very, very excited!” So says Dr. Monica Perez, who is running the first human trial for a potential new wonder drug being developed by a tiny but well-financed life sciences start-up, NervGen Pharma Corp. ...
Knox Henderson | July 2, 2024 |

Minnesota helium project well positioned to help alleviate global shortage

By Marc Farrington In February this year, Pulsar Helium Inc (Pulsar) ( TSXV:PLSR ) announced extraordinarily high helium concentrations of up to 13.8% from its Jetstream No. 1 appraisal well drilled at its Topaz project in Minnesota. This has positioned Topaz as th...
Research | May 9, 2024 |

Why the Tonopah Gold Project is one to watch

The following is a transcription of the above video, and The Market Online has edited it for clarity . Viva Gold Corp. (TSXV:VAU) is committed to developing the Tonopah Gold Project in an environmentally and socially responsible fashion. CEO James Hesketh join...
Ryan Dhillon | April 12, 2024 |

Buzz on the Bullboards: Pulling gains out of volatile territory

As the global economy navigates uncertainties, investors have been watching the performance of key stock markets for insights into prevailing sentiment and economic health. Over the past week, the TSX and the trio of indices on Wall Street – the Dow Jones Industrial A...
Jonathon Brown | March 28, 2024 |

Can NervGen keep a lid on explosive news?

Speculation of early “evidence” of successful proof-of-concept human trials sparks stock rallies Trial volunteers taking a placebo are offered the real deal in a follow-up trial as a “reward” The company&Clo...
Knox Henderson | March 20, 2024 |
1 2 3 4 5 6 7 8 9 10 ...